Material
Synthetic tetrapeptide
Mitochondrial research
SS-3110 MG
A tetrapeptide investigated in mitochondrial membrane, oxidative-stress and cellular-energy models.
Product code SS010
MaterialSynthetic tetrapeptide
Research contextMitochondrial peptide research.
Veyvanta / profile
Compound profile
* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.
Composition
Single peptide material.
Research context
Mitochondrial peptide research.
Research interest
Why it draws attention
Its mitochondria-targeted design keeps SS-31 prominent in research on cardiolipin, cellular energy, redox balance, and age-related muscle performance.
Signals researchers are following
- 01
Mitochondrial membrane and cardiolipin biology
- 02
Cellular energetics, oxidative stress, and muscle function
Evidence levelMixed human and preclinical evidence
Published evidence / research profile
What the published research shows
A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.
Evidence levelMixed human and preclinical evidence
Common research directions
- Mitochondrial membrane and cardiolipin biology
- Cellular energetics, oxidative stress, and muscle function
Reported findings
Elamipretide research spans mitochondrial mechanisms and human clinical programs. In September 2025, FDA granted accelerated approval to the branded formulation Forzinity to improve muscle strength in Barth syndrome patients weighing at least 30 kg; confirmatory evidence is required.
How to read the evidence
SS-31 is known as elamipretide in clinical research. Forzinity's approval is specific to its formulation and indication; it does not establish equivalence, approved use, or general aging benefits for this research material.
Selected references
Forzinity: Accelerated Approval for Barth SyndromeFDA (September 2025)View sourceSS-31 in an Aged Cerebromicrovascular Injury ModelGeroScience (2025)View sourceElamipretide in Geographic Atrophy: ReCLAIM-2Ophthalmol Sci (2024)View sourceElamipretide in Primary Mitochondrial Myopathy: MMPOWER-3Neurology (2023)View sourceElamipretide and ADP Sensitivity in Aged MitochondriaGeroScience (2023)View sourceSS-31 Improves Exercise Tolerance in Aged MiceRedox Biol (2019)View source
This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.
Lab math
Reconstitution & measurement calculator
Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.
Research product
Research productSS-31 / 10 MG
Calculation basisSS-31
Calculated measurement
Enter a positive diluent volume and target amount to calculate.
A calculation, not a protocol
This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.
Product & historical codes
Current batch record
The product code identifies this material and declared strength. Supplier lot, expiry and analytical documentation are recorded separately when available.
- Batch
- SS320
- Expiry
- 5/4/28
Veyvanta internal batch record.
Find a label code
Direct product QR
This permanent link opens this exact product and strength. It does not certify an individual vial.
veyvanta.com/p/SS010Mitochondrial research
